Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Week in Review: $1.2 Billion in China Life Science Deals, IPOs and Financings

Deals and Financings   A Sino Biopharma subsidiary out-licensed ex-China rights for a fibrosis therapy to Graviton Bio of New York in a deal worth up to $517.5 million; Yangtze River Pharma signed a $338 million deal for China rights to a gastroesophageal reflux treatment from South Korea 's Daewoong Pharma; Connect Biopharma, a Suzhou-San Diego company, raised $191 million in a NASDAQ IPO to support its portfolio of autoimmune treatments; Hansoh Pharma entered an $122 million agreement to acquire Greater China rights to a novel antifungal from Synexis of New Jersey; Shanghai 's Hanyu Medical completed a $77 million D+ funding for its minimally invasive mitral valve device, ValveClamp; Shanghai WuXi Biologics will acquire a 90% interest in a Suzhou CDMO backed by CBC Group and will collaborate to develop biologics for CBC portfolio companies; WuXi Biologics also bought a biotech drug manufacturing facility in Hangzhou from Pfizer China that had been manufacturing biosimilars; Hangzhou Chance Pharma acquired greater China rights for an inhaled drug aimed at pulmonary arterial hypertension from US-based Aerami Therapeutics; BeiGene will collaborate with Shanghai 's 111 Inc. to develop internet based retail drug delivery and patient management services; Industry Insights   Two months into 2021, the momentum from 2020's record-setting levels of China life science activity has continued into the new year; Trials and Approvals   Harbour BioMed dosed the first patient in the China arm of a global Phase III trial of a novel treatment for moderate-to-severe dry eye disease; Adagene, a Suzhou-San Francisco immunotherapy company, started a global Phase I trial of a novel CTLA-4 mAb to treat solid tumors. Stock Symbols: (HK: 1177) (NSDQ: CNTB) (HK: 3692) (NSDQ: SCYX) (HK: 2269) (NSDQ: BGNE; HK:06160) (NSDQ: YI) (HK: 02142) (NSDQ: ADAG) Share this with colleagues: // //
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.